Inspire Investing LLC Takes $1.87 Million Position in Guardian Pharmacy Services, Inc. $GRDN

Inspire Investing LLC acquired a new position in Guardian Pharmacy Services, Inc. (NYSE:GRDN) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 49,565 shares of the company’s stock, valued at approximately $1,867,000. Inspire Investing LLC owned 0.08% of Guardian Pharmacy Services as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in GRDN. Ameritas Investment Partners Inc. increased its holdings in Guardian Pharmacy Services by 26.5% during the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after buying an additional 345 shares during the last quarter. California State Teachers Retirement System boosted its stake in shares of Guardian Pharmacy Services by 3.4% during the 4th quarter. California State Teachers Retirement System now owns 17,983 shares of the company’s stock worth $541,000 after acquiring an additional 593 shares during the last quarter. Police & Firemen s Retirement System of New Jersey grew its position in shares of Guardian Pharmacy Services by 20.4% during the 4th quarter. Police & Firemen s Retirement System of New Jersey now owns 6,070 shares of the company’s stock valued at $183,000 after acquiring an additional 1,028 shares during the period. Price T Rowe Associates Inc. MD grew its position in shares of Guardian Pharmacy Services by 13.4% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 11,885 shares of the company’s stock valued at $358,000 after acquiring an additional 1,409 shares during the period. Finally, Clearstead Advisors LLC increased its stake in shares of Guardian Pharmacy Services by 196.3% in the 4th quarter. Clearstead Advisors LLC now owns 2,628 shares of the company’s stock worth $79,000 after purchasing an additional 1,741 shares in the last quarter.

Guardian Pharmacy Services Stock Performance

Shares of Guardian Pharmacy Services stock opened at $41.92 on Wednesday. Guardian Pharmacy Services, Inc. has a fifty-two week low of $19.30 and a fifty-two week high of $44.00. The company has a market capitalization of $2.09 billion, a P/E ratio of 50.50, a P/E/G ratio of 2.65 and a beta of 0.08. The company has a fifty day moving average of $38.93 and a 200 day moving average of $35.14.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.29 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.05. Guardian Pharmacy Services had a return on equity of 30.72% and a net margin of 3.64%.The business had revenue of $336.60 million for the quarter, compared to analysts’ expectations of $329.89 million. During the same period last year, the firm earned $0.22 earnings per share. The business’s quarterly revenue was up 2.2% on a year-over-year basis. Analysts forecast that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts recently weighed in on GRDN shares. Truist Financial lifted their target price on Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a “buy” rating in a research report on Wednesday, June 17th. Bank of America upped their price target on Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Oppenheimer raised their price objective on Guardian Pharmacy Services from $38.00 to $43.00 and gave the stock an “outperform” rating in a research note on Thursday, May 7th. Raymond James Financial reaffirmed an “outperform” rating and set a $40.00 price objective on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. Finally, Jefferies Financial Group started coverage on shares of Guardian Pharmacy Services in a report on Monday, March 30th. They issued a “buy” rating and a $44.00 target price for the company. Seven investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $42.83.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.